Dr. Alexander Pantelyat cares for patients with movement disorders such as Parkinson's disease and related syndromes, essential tremor, dystonia, chorea and normal pressure hydrocephalus. He also provides botulinum toxin injections for movement disorders and is involved in deep brain stimulation programming and intraoperative neurophysiological monitoring.His research explores atypical parkinsonian disorders, such as dementia with Lewy bodies, progressive supranuclear palsy, corticobasal syndrome/degeneration and multiple system atrophy; cognitive aspects of movement disorders; and music-based rehabilitation of neurodegenerative diseases.Dr. Pantelyat earned his medical degree from Temple University School of Medicine in Philadelphia, where he was elected a member of the Alpha Omega Alpha Honor Medical Society and received the Matthew T. Moore Prize in Neurology. He completed his residency training in Neurology ​at the University of Pennsylvania in Philadelphia, and a fellowship in movement disorders at the University of Pennsylvania/Philadelphia VA Medical Center. As part of his fellowship, Dr. Pantelyat also completed the Clinical Research Certificate Program at the Center for Clinical Epidemiology and Biostatistics. He is a 2013 American Academy of Neurology Palatucci Advocacy Leader and grant recipient. Dr. Pantelyat is rated as a Distinguished provider by MediFind in the treatment of Supranuclear Ocular Palsy. His top areas of expertise are Progressive Supranuclear Palsy, Progressive Supranuclear Palsy Atypical, Supranuclear Ophthalmoplegia, and Corticobasal Degeneration.

Dr. Jee Bang cares for patients with disorders of cognition and movement, such as Huntington disease, progressive supranuclear palsy, corticobasal degeneration, multiple system atrophy, dementia with Lewy bodies, frontotemporal dementia, and Alzheimer disease. Dr. Bang is rated as an Advanced provider by MediFind in the treatment of Supranuclear Ocular Palsy. Her top areas of expertise are Huntington Disease, Mcleod Neuroacanthocytosis Syndrome, Supranuclear Ocular Palsy, and Progressive Supranuclear Palsy.

Melissa Blakeman, M.D., is the regional medical director for Johns Hopkins Community Physicians (JHCP) in the Maryland suburbs region. Dr. Blakeman practices internal medicine at JHCP in North Bethesda, Maryland, where she previously served as the office medical director. Dr. Blakeman serves as the Medical Director, Patient Access, for JHCP primary care. She is on several committees, including the Baldridge, Recruitment and Retention, Research and Projects, and Practice Standards Committees. Dr. Blakeman earned her medical degree from the University of Pittsburgh School of Medicine. She completed a residency in internal medicine at the George Washington University School of Medicine and was the chief resident for primary care. Dr. Blakeman has also completed Johns Hopkins Medicine's Transforming Health Systems for Accountable Care Executive Education Program and Leadership Development Program. Dr. Blakeman has been repeatedly named a Top Doctor by Washingtonian Magazine and Washington Consumers' Checkbook. Dr. Blakeman is rated as an Advanced provider by MediFind in the treatment of Supranuclear Ocular Palsy. Her top areas of expertise are Progressive Supranuclear Palsy Atypical, Progressive Supranuclear Palsy, Supranuclear Ophthalmoplegia, and Supranuclear Ocular Palsy.

Dr. Ankur Butala specializes in the care of persons with complex neuropsychiatric conditions, including persons with advanced Parkinson Disease or other movement or neurodegenerative disorders. Upon graduating from a selective Physician-Scientist program at Albany Medical College, he joined the University of Massachusetts in an uncommon residency in both Neurology and Psychiatry. Dual-trained neuropsychiatrists such as Dr. Butala have experience with: Parkinson Disease and atypical Parkinsonism, Huntington Disease, Ataxia, Dystonia, early-onset dementia, traumatic brain injury and chronic traumatic encephalopathy, autism spectrum disorders, medication refractory mood and psychotic disorders, epilepsy and functional neurological disorders. In residency, he developed an interest in circuit models of brain function and how non-pharmacological approaches such as Neuromodulation and brain stimulation may be used to address treatment-resistant conditions. Consequently, he joined Johns Hopkins University School of Medicine as a Clinical and Research Fellow from 2015 to 2018, where he developed a skill set including deep brain stimulation, non-invasive brain stimulation (tDCS), and measurement of eye movements. Currently, Dr. Butala's clinical and research interests are in diagnosing and managing persons with advanced Parkinson's Disease, movement disorders, and neuropsychiatric conditions using neuromodulation, cannabinoids, and entheogens. He has ongoing multidisciplinary collaborations with colleagues at the Whiting School of Engineering - Center of Speech & Language Processing in using Machine-Learning Models and Artificial Intelligence to improve the detection and diagnosis of Movement and Neuropsychiatric disorders. LinkedIn https://www.linkedin.com/in/ankurbutalamd Videos Neurology: Junior Faculty Spotlight. Dr. Butala is rated as an Advanced provider by MediFind in the treatment of Supranuclear Ocular Palsy. His top areas of expertise are Parkinson's Disease, Corticobasal Degeneration, Movement Disorders, Drug Induced Dyskinesia, and Deep Brain Stimulation.

Joseph Savitt is a Neurologist in Baltimore, Maryland. Dr. Savitt is rated as a Distinguished provider by MediFind in the treatment of Supranuclear Ocular Palsy. His top areas of expertise are Parkinson's Disease, Movement Disorders, Supranuclear Ophthalmoplegia, Supranuclear Ocular Palsy, and Gastrostomy. Dr. Savitt is currently accepting new patients.

Stephen Reich is a Neurologist in Baltimore, Maryland. Dr. Reich is rated as a Distinguished provider by MediFind in the treatment of Supranuclear Ocular Palsy. His top areas of expertise are Movement Disorders, Parkinson's Disease, Supranuclear Ophthalmoplegia, Deep Brain Stimulation, and Gastrostomy. Dr. Reich is currently accepting new patients.

Dr. Moukheiber trained in neurology at Tufts Medical Center and completed his fellowship in movement disorders at Johns Hopkins. His primary interests include using telehealth/teleneurology to help bridge the gap between tertiary care available in well-funded facilities and the dearth of it in significantly underserved and remote areas; especially pertaining to movement disorders in general and ataxia in particular. He has worked with a number of non-government organizations and founded his own entity that provides home health care in the form of advanced nursing, physical therapy and occupational therapy to underserved communities in third world countries, with particular emphasis on neurodegenerative diseases. Dr. Moukheiber is rated as an Experienced provider by MediFind in the treatment of Supranuclear Ocular Palsy. His top areas of expertise are Stiff Person Syndrome, Movement Disorders, Parkinson's Disease, and Drug Induced Dyskinesia.

As the director of the Johns Hopkins Movement Disorders Division, Dr. Kelly Mills cares for patients who have movement disorders such as Parkinson’s disease, atypical parkinsonism, dystonia, ataxia, tremor and Huntington’s disease. He also evaluates and manages patients needing deep brain stimulation to manage their movement symptoms and provides botulinum toxin treatment for various disorders. In his research, Dr. Mills explores the cognitive dysfunction that can occur in movement disorders such as Parkinson’s disease. He is particularly interested in describing the role of the basal ganglia in cognition, especially in the context of various diseases that can affect this structure. His work focuses on clarifying how certain treatments might impact cognitive and psychiatric problems. For instance, Dr. Mills studies how deep brain stimulation, when used to treat movement symptoms, can impact cognitive function such as attention, memory or impulsivity. Dr. Mills is a Maryland native and a graduate of the University of Maryland School of Medicine, where he developed an interest in neurology and movement disorders. He trained at the University of California, San Francisco, where he completed his neurology residency as well as a clinical and research fellowship in movement disorders, with a particular emphasis on deep brain stimulation to treat Parkinson’s disease, tremor and dystonia. Dr. Mills is rated as an Experienced provider by MediFind in the treatment of Supranuclear Ocular Palsy. His top areas of expertise are Movement Disorders, Parkinson's Disease, Essential Tremor, and Drug Induced Dyskinesia.

Liana Rosenthal, M.D. is an Assistant Professor in the Department of Neurology at Johns Hopkins University School of Medicine in Baltimore, Maryland. Dr. Rosenthal completed medical school at Johns Hopkins with an internship at Johns Hopkins Bayview Medical Center. She completed her neurology residency and movement disorder fellowship at The Johns Hopkins Hospital. Dr. Rosenthal is rated as an Experienced provider by MediFind in the treatment of Supranuclear Ocular Palsy. Her top areas of expertise are Movement Disorders, Parkinson's Disease, Olivopontocerebellar Atrophy, and Spinocerebellar Ataxia.

Neurologist Ashley Paul specializes in movement disorders and also serves as a clinician educator. Dr. Paul has expertise in Parkinson's Disease, atypical parkinsonism, tremors, chorea, dystonia, ataxia, restless leg syndrome, rapid eye movement sleep behavioral disorders, periodic limb movement of sleep and deep brain stimulation. She offers botulinum toxin injections for the treatment of dystonia. Dr. Paul is rated as an Experienced provider by MediFind in the treatment of Supranuclear Ocular Palsy. Her top areas of expertise are Movement Disorders, Drug Induced Dyskinesia, Hereditary Ataxia, and Acute Cerebellar Ataxia.

Prior to joining the Mid-Atlantic Epilepsy and Sleep Center, Dr. Jonathan Ross was Director of The New England Epilepsy Institute, a division of New England Neurological Associates (NENA) in Lawrence, Massachusetts. He also served as head of the Neurology division at NENA. After graduating medical school in 1991, Dr. Ross completed postgraduate training at Harvard Medical School and Boston University School of Medicine, and also served as Teaching Fellow at Harvard and Boston University. Dr. Ross is an active member of the American Epilepsy Society, American Clinical Neurophysiology Society, Massachusetts Medical Society, and the American Academy of Neurology. Dr. Ross is rated as an Experienced provider by MediFind in the treatment of Supranuclear Ocular Palsy. His top areas of expertise are Seizures, Memory Loss, Autosomal Dominant Partial Epilepsy with Auditory Features, and Benign Rolandic Epilepsy.

Dr. Argye Hillis is a professor of Neurology, with joint faculty appointments in Physical Medicine and Rehabilitation and in Cognitive Science. She is also the Sheikh Khalifa Stroke Institute Professor of Acute Stroke Diagnoses and Management. Prior to medical training and neurology residency, Dr. Hillis worked as a speech-language pathologist, and conducted clinical research focusing on understanding and treating aphasia and hemispatial neglect. She has brought these areas of experience to impact on her clinical research in neurology, which involves cognitive and neuroimaging studies of aphasia and hemispatial neglect due to acute stroke and focal dementias. She has published extensively on these topics in journals and textbooks. Dr. Hillis is Associate Editor of Stroke and has served as Associate editor of Brain, Annals of Neurology, Aphasiology, American Journal of Speech-Language Pathology, Neurocase, Cognitive Neuropsychology, and Language and Cognitive Processes and served as co-Editor and Chief of Behavioral Neurology. Dr. Hillis serves as the Executive Vice Chair of the Department of Neurology and the Director of the Cerebrovascular Division of Neurology at Johns Hopkins. Dr. Hillis is rated as an Experienced provider by MediFind in the treatment of Supranuclear Ocular Palsy. Her top areas of expertise are Primary Progressive Aphasia, Stroke, Frontotemporal Dementia, Thrombectomy, and Gastrostomy.

Dr. Chua is an assistant professor in the Department of Neurology and Division of Movement Disorders at Johns Hopkins. He received his training at the University of Michigan, where he obtained medical and graduate degrees, then completed a residency in neurology and a combined clinical/research fellowship in movement disorders and neurodegeneration. Dr. Chua’s primary research interests are in neurodegenerative disease with a special focus on autophagy — an essential housekeeping process in cells that is particularly important for the health of neurons. Autophagy may provide a way to break down the buildup of toxic proteins found in neurodegenerative diseases, thereby forming the basis of new treatment strategies for these incurable conditions. He has received multiple research grants to support his work, including from the National Institute of Neurological Disorders and Stroke and the American Academy of Neurology (AAN). He is the primary author and co-author of multiple peer-reviewed scientific publications and online learning modules as part of the AAN. Dr. Chua is a contributing author to The Little Black Book of Neurology by Osama Zaidat, Alan Lerner and J. Douglas Miles, and he has been a peer reviewer for the scientific journals Autophagy, eLife and Neurobiology of Disease. He currently serves on the scientific advisory board for the Don't Forget Morgan Foundation, a private organization supporting research and outreach regarding the disease beta-propeller protein-associated neurodegeneration (BPAN). For more information about the Chua Lab, please visit https://chualab.jhmi.edu. Dr. Chua is rated as an Experienced provider by MediFind in the treatment of Supranuclear Ocular Palsy. His top areas of expertise are Primary Lateral Sclerosis, Parkinson's Disease, Movement Disorders, and Camptocormism.

Dr. Stephen Grill is currently an Assistant Professor at Johns Hopkins University (JHU) in Baltimore and Chair of the Medical Advisory Board of the Parkinson Foundation of the National Capital Area (PFNCA). Dr. Grill received a Ph.D. in Neuroscience and an M.D. from Northwestern University. He then completed a neurology residency at Washington University and a fellowship in movement disorders at the National Institutes of Health. He was the founder of Parkinson’s & Movement Disorders Center of Maryland which is now Neurology Consultants – Parkinson’s & Movement Disorders Center of Maryland, a member of Johns Hopkins Regional Physicians. His research interests include how sensory information is used in the control of movement and how improper use of sensory information may lead to motor impairment. He treats persons with advanced Parkinson’s disease employing advanced technologies, such as Deep Brain Stimulation. Dr. Grill is rated as an Experienced provider by MediFind in the treatment of Supranuclear Ocular Palsy. His top areas of expertise are Parkinson's Disease, Movement Disorders, Drug Induced Dyskinesia, and Restless Legs Syndrome.

Milap Nowrangi, M.D., MS, is an assistant professor of psychiatry and behavioral sciences at The Johns Hopkins University School of Medicine. Dr. Nowrangi specializes in the diagnosis and treatment of age-related cognitive disorders, including Alzheimer's Disease and related dementias. He also is interested in the treatment or management of behavioral and cognitive sequelae of neurological diseases, including those caused by traumatic brain injury, stroke, epilepsy or toxic exposures. Dr. Nowrangi is rated as an Experienced provider by MediFind in the treatment of Supranuclear Ocular Palsy. His top areas of expertise are Alzheimer's Disease, Dementia, Bipolar Disorder (BPD), and Neuronal Intranuclear Inclusion Disease (NIID).

Dr. Scholz is a neurologist and geneticist specializing in neurodegenerative disorders such as Parkinson's disease, atypical parkinsonism and dementia syndromes. She received her medical degree from the Medical University Innsbruck, Austria. Following graduation, she was a postdoctoral fellow at the National Institutes of Health under the supervision of Drs. Andrew Singleton and John Hardy. She obtained a Ph.D. in neurogenomics from the University College London, UK in 2010. She then moved to Baltimore to complete her neurology residency training at Johns Hopkins. In 2015 Dr. Scholz received the McFarland Transition to Independence Award for Neurologist-Scientists. She is Lasker Clinical Research Scholar at the National Institute of Neurological Disorders and Stroke focusing on genetic causes of neurodegenerative syndromes, and an adjunct faculty member at Johns Hopkins' department of neurology. Dr. Scholz is rated as an Experienced provider by MediFind in the treatment of Supranuclear Ocular Palsy. Her top areas of expertise are Lewy Body Dementia (LBD), Multiple System Atrophy, Movement Disorders, and Parkinson's Disease.

Dr. Katz completed his undergraduate degree in Neuroscience at Colgate University, his MD at SUNY/Buffalo School of Medicine (his home town), his Neurology residency at Duke University Medical Center, and his Neuro-Ophthalmology fellowship at the University of Michigan/Kellogg Eye Center. Dr. Katz specializes in Neuro-Ophthalmology and Neurology. Dr. Katz has been a primary investigator in clinical trials in Neuro-Ophthalmology and holds academic appointments at Georgetown University Hospital and Howard University Hospital. A list of his publications can be found on. Dr. Katz is rated as an Experienced provider by MediFind in the treatment of Supranuclear Ocular Palsy. His top areas of expertise are Optic Neuritis, Meningitis, Arachnoiditis, and Temporal Arteritis.

Dr. George Ricaurte has a weekly clinic that focuses on Parkinsons disease and other movement disorders. In addition, he attends on the consult and in-patient neurology services at Johns Hopkins Bayview Medical Center. Dr. Ricaurte's research interests center on amphetamine-type stimulants and their potential to damage brain monoamine-containing neurons, including dopamine neurons (which degenerate in Parkinsons disease). Dr. Ricaurte and his colleagues are particularly interested in mechanisms of dopamine nerve cell degeneration. The long-term goal of this neurotoxicology research is to help find ways to prevent - or retard - the progression of Parkinsons disease and related neurodegenerative disorders. Dr. Ricaurtes work also has implications for the drug abuse field and substance abuse neuropsychiatric disorders. Dr. George Ricaurte received his medical degree from Northwestern University Medical School and his doctorate in Pharmacology from the University of Chicago. He then completed his residency in neurology at Stanford University Medical Center and did a one year fellowship at the Parkinsons Institute in California. Dr. Ricaurte is rated as an Experienced provider by MediFind in the treatment of Supranuclear Ocular Palsy. His top areas of expertise are Parkinson's Disease, Movement Disorders, Lewy Body Dementia (LBD), and Essential Tremor.

Marcelino Albuerne is a primary care provider, practicing in Family Medicine in Catonsville, Maryland. Dr. Albuerne is rated as an Experienced provider by MediFind in the treatment of Supranuclear Ocular Palsy. His top areas of expertise are Glycine Encephalopathy, Anemia, Familial Hypertension, Gastrostomy, and Endoscopy.

Aviva Ellenstein is a Neurologist in Rockville, Maryland. Dr. Ellenstein is rated as an Experienced provider by MediFind in the treatment of Supranuclear Ocular Palsy. Her top areas of expertise are Movement Disorders, Parkinson's Disease, Secondary Parkinsonism, and Focal Dystonia. Dr. Ellenstein is currently accepting new patients.